AUSTRALIA
Pharmaceutical patent term extension in Australia
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial importance, and in recent years have become of particular interest...
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial...
Read More
AUSTRALASIA
Full Federal Court Doubles Down on Pharmaceutical Patent Term Extensions
In two appeal judgements handed down concurrently on 18 March 2022, the Full Federal Court has clarified that a pharmaceutical patent term extension (PTE) for a patent should be...
In two appeal judgements handed down concurrently on 18 March 2022, the Full Federal Court has clarified that a...
Read More
AUSTRALASIA
Pharmaceutical patent term extension update: the Commissioner appeals the Ono decision and the Australian Patent Office releases a practice update
The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents FCA 643 (“Ono”) relating to pharmaceutical patent term extensions...
The Australian Patent Commissioner has appealed the Federal Court decision of Ono Pharmaceutical Co, Ltd v Commissioner of Patents...
Read More
AUSTRALASIA
The Evolving Patentability of Genetic Material in Australia post-Myriad
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in regard to what genetic material may be patentable under Australian...
A number of decisions by the Australian Patent Office following the 2015 “Myriad” decision have provided further clarity in...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe